Deadline for applications : January 15, 2014.

Description :

We seek a talented and motivated post-doc to develop computational methods for inferring the molecular basis of genetic diseases by integration of personal omics data. Research topics include: identifying causal mutations of rare disease patients by meta-analysis; inferring disease-causing molecular pathways from genotype, human phenotypes, and omics profile of patient-derived cell lines; and causal inference from longitudinal omics studies of patients. The developed methods will be applied to analyze data from our medical collaborators.

Candidates must either hold a PhD in computational biology or bioinformatics, or hold a PhD in physics, statistics, or applied mathematics with practical experience with high-dimensional data analysis. Experience in quantitative genetics is a plus. Applicants must have a proven publication record and an interest for translational research.

The Gagneur lab is a young, lively and multidisciplinary group with a research focus on systems genetics and gene regulation. It is located at the Gene Center of the LMU (University of Munich), an interdisciplinary institution whose 16 independent research groups investigate the regulation of gene expression at all levels - from the underlying molecular mechanisms to the biological system. The institute is located on the biomedical research campus Munich-Grosshadern, offering a dynamic, interactive and internationally oriented research environment. The dynamism of Munich and the proximity of the Alps provide an excellent quality of life.

The salary is according to the TV-L (German academic salary scale).
Applications including a cover letter, CV, and references must be sent by January 15th 2014 to Julien Gagneur (gagneur@genzentrum.lmu.de)

About the lab: http://www.gagneur.genzentrum.lmu.de

James Webb Space Telescope's Revelations: Since its launch, the James Webb Space Telescope has provided unprecedented insights into the cosmos, unveiling details about the early universe and distant galaxies that were previously beyond our reach.

Re-establishing Contact with Voyager 1: In a testament to human ingenuity, scientists successfully re-established communication with Voyager 1, the spacecraft launched in 1977 now traversing interstellar space, offering data from the far reaches of our solar system.

Advancements in Human Biology: The global cell atlas project released its initial findings, mapping human cells with unprecedented detail, akin to a "Google Maps for the body." Additionally, the first complete map of a fruit fly's brain was unveiled, promising new insights into neurological diseases.

Public Health Milestones: The rollout of the first malaria vaccines and the commencement of late-stage clinical trials for a new tuberculosis vaccine—the first in over a century—marked significant strides in combating these diseases. Efforts against HIV/AIDS also showed promising progress, particularly in Africa.

Weight-Loss Drugs' Expanded Potential: Medications initially developed for weight loss demonstrated potential in treating a range of other diseases, indicating a broader therapeutic application than previously anticipated.

Robotics and Quantum Computing: Technological advancements brought robots capable of performing more complex tasks and moved quantum computing closer to practical, real-world applications, heralding a new era in computing and automation.

Synthetic Biology Concerns: Leading researchers, including Nobel laureates, raised alarms about the potential risks associated with synthetic biology, particularly the creation of "mirror bacteria," underscoring the need for careful regulation in this rapidly evolving field.

Climate Change Insights: Studies indicated that global CO₂ emissions plateaued with only a 0.1% increase in 2023, suggesting a potential turning point in emission trends. However, concerns about climate tipping points, such as the Atlantic Meridional Overturning Current, highlighted the urgency for continued action.

New Antibiotic Class Discovered: A novel class of antibiotics targeting multi-drug resistant bacteria was discovered, offering hope in the fight against antibiotic-resistant infections.